Literature DB >> 26155541

A Rare Case of Myxedema Coma with Neuroleptic Malignant Syndrome (NMS).

Siddharth Dixit1, Manoj Kumar Dutta2, Mayank Namdeo3.   

Abstract

Myxedema coma or hypothyroid crisis is an endocrine emergency and needs ICU management. Neuroleptic malignant syndrome (NMS) is another medical emergency which needs high degree of clinical suspicion else mortality can be high. There is a paradox in co existence of myxedema coma and NMS. While one is hypometabolic state another is hypermetabolic state and both can be precipitated by antipsychotics use. Hypothermia and flaccidity commonly expected in myxedema coma may mask fever and rigidity of classical NMS contributing to diagnostic problem and treatment delay. Scientific literature on coexistance of myxedema coma and NMS is sparse. We hereby report first case with coexisting myxedema coma and NMS in a patient of schizophrenia treated with antipsychotic, where classical symptoms of NMS were masked by myxedema coma. Prompt diagnosis and effective management by a team resulted in favourable outcome in our patient. This case is reported to alert intensive care physicians to atypical manifestations of NMS in presence of hypothyroidism.

Entities:  

Keywords:  Atypical antipsychotics; Atypical neuroleptic malignant syndrome; Hypothyroid crisis; Primary hypothyroidism

Year:  2015        PMID: 26155541      PMCID: PMC4484133          DOI: 10.7860/JCDR/2015/13008.5868

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.

Authors:  C D Hatch; B C Lund; P J Perry
Journal:  Pharmacotherapy       Date:  2001-08       Impact factor: 4.705

Review 2.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

3.  Hypothermic coma associated with thioradizine in a myxedematous patient.

Authors:  D Lanska; H H Harsch
Journal:  J Clin Psychiatry       Date:  1984-04       Impact factor: 4.384

Review 4.  [Coma in myxedema--a rare complication of hypothyroidism. Possible iatrogenic factors should be taken into account].

Authors:  R Hehrmann
Journal:  Fortschr Med       Date:  1996-12-10

5.  Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.

Authors:  Umit Tural; Emin Onder
Journal:  Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.188

6.  Myxedema coma associated with combination aripiprazole and sertraline therapy.

Authors:  Chelsea O Church; Erin C Callen
Journal:  Ann Pharmacother       Date:  2009-11-24       Impact factor: 3.154

7.  Neuroleptic malignant syndrome and atypical antipsychotic drugs.

Authors:  Jambur Ananth; Sharat Parameswaran; Sarath Gunatilake; Karl Burgoyne; Taghrid Sidhom
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

8.  Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.

Authors:  Lara S Picard; Shane Lindsay; Jeffrey R Strawn; Rakesh M Kaneria; Nick C Patel; Paul E Keck
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

9.  The neuroleptic malignant syndrome: an Indian experience.

Authors:  M P Chopra; S S Prakash; R Raguram
Journal:  Compr Psychiatry       Date:  1999 Jan-Feb       Impact factor: 3.735

Review 10.  Clinical concepts on thyroid emergencies.

Authors:  Giampaolo Papi; Salvatore Maria Corsello; Alfredo Pontecorvi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-01       Impact factor: 5.555

View more
  4 in total

1.  Recurrent noncirrhotic hyperammonemia causing acute metabolic encephalopathy in a patient with a continent ileocecal pouch: a case report.

Authors:  T M Skipina; S Macbeth; E L Cummer; O L Wells; S Kalathoor
Journal:  J Med Case Rep       Date:  2021-05-22

2.  An Atypical Case of Myxedema Coma with Concomitant Nonconvulsive Seizure.

Authors:  Pratik Patel; Mikhael Bekkerman; Cristina Varallo-Rodriguez; Rajendra Rampersaud
Journal:  Case Rep Crit Care       Date:  2016-10-30

3.  Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.

Authors:  Fan Zhang; Parisa Kanzali; Vadim Rubin; Chris Paras; Joel Goldman
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

Review 4.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.